MST1P2: A Potential Drug Target for Cancer and Other Diseases

Target Name: MST1P2

NCBI ID: G11209

MST1P2

MST1P2: A Potential Drug Target for Cancer and Other Diseases

MST1P2 (Mesothelin-Specific Tissue Marker-2) is a protein that is expressed in various tissues throughout the body, including the skin, heart, lungs, and brain. It is a member of the mesothelin family, which is known for its involvement in cell signaling and tissue organization. MST1P2 has been identified as a potential drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key features of MST1P2 is its ability to interact with other proteins that are involved in cell signaling pathways. This interaction allows MST1P2 to play a role in the regulation of cell growth, differentiation, and survival. MST1P2 has been shown to interact with several different proteins, including the transcription factor NF-kappa-B and the protein TGF-β. These interactions may help to regulate the activity of these proteins and influence the behavior of cells.

Another important function of MST1P2 is its role in cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. MST1P2 is involved in the regulation of cell adhesion by interacting with the protein E-cadherin. This interaction helps to maintain the integrity of tissues and organs and may be important for their development and maintenance.

In addition to its role in cell signaling and adhesion, MST1P2 has also been shown to play a role in the regulation of cell cycle progression. The cell cycle is the process by which cells divide and replicate their genetic material. MST1P2 is involved in the regulation of cell cycle progression by interacting with the protein p21. This interaction helps to prevent the cell cycle from rolling over and ensures that the cell stays in a fixed state of growth and division.

MST1P2 has also been shown to play a role in the regulation of angiogenesis, which is the process by which new blood vessels form in the body. MST1P2 is involved in the regulation of angiogenesis by interacting with the protein PDGFR-尾. This interaction helps to control the activity of PDGFR-尾 and influence the formation of new blood vessels.

In conclusion, MST1P2 is a protein that plays a critical role in the regulation of cell signaling, adhesion, and cycle progression, as well as angiogenesis. As a potential drug target or biomarker, MST1P2 is a promising target for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of MST1P2 in these processes and to develop effective therapies based on this protein.

Protein Name: Macrophage Stimulating 1 Pseudogene 2

The "MST1P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MST1P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets